XML 111 R45.htm IDEA: XBRL DOCUMENT
v3.22.0.1

Fair Value Measurements (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2021
Fair Value Disclosures [Abstract] |
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis |
Assets and (Liabilities) Carried at Fair Value by Hierarchy Level as of December 31, 2021
| Total | Quoted Prices in Active Markets for Identical Assets (Level 1) | Significant Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3)
Assets accounted for at fair value on a recurring basis |  |  |  |
Fixed maturities, AFS |  |  |  |
Asset backed securities ("ABS") | $ | 1,135 |  | $ | — |  | $ | 1,135 |  | $ | — |
Collateralized loan obligations ("CLOs") | 3,025 |  | — |  | 2,768 |  | 257 |
Commercial mortgage-backed securities ("CMBS") | 4,119 |  | — |  | 3,923 |  | 196 |
Corporate | 18,707 |  | — |  | 17,089 |  | 1,618 |
Foreign government/government agencies | 910 |  | — |  | 905 |  | 5 |
Municipal | 8,257 |  | — |  | 8,257 |  | — |
Residential mortgage-backed securities ("RMBS") | 3,643 |  | — |  | 3,315 |  | 328 |
U.S. Treasuries | 3,051 |  | 882 |  | 2,169 |  | — |
Total fixed maturities | 42,847 |  | 882 |  | 39,561 |  | 2,404 |
Equity securities, at fair value | 2,094 |  | 1,453 |  | 577 |  | 64 |
Derivative assets |  |  |  |
Credit derivatives | 2 |  | — |  | 2 |  | — |
Foreign exchange derivatives | 6 |  | — |  | 5 |  | 1 |
Interest rate derivatives | (1) |  | — |  | (1) |  | — |
Total derivative assets [1] | 7 |  | — |  | 6 |  | 1 |
Fixed maturities, at fair value using the fair value option ("FVO") [2] | 160 |  | — |  | — |  | 160 |
Short-term investments | 3,697 |  | 1,627 |  | 1,990 |  | 80 |
Total assets accounted for at fair value on a recurring basis | $ | 48,805 |  | $ | 3,962 |  | $ | 42,134 |  | $ | 2,709 |
Liabilities accounted for at fair value on a recurring basis |  |  |  |
Derivative liabilities |  |  |  |
Credit derivatives | $ | (4) |  | $ | — |  | $ | (4) |  | $ | — |
Foreign exchange derivatives | — |  | — |  | 1 |  | (1) |
Interest rate derivatives | (45) |  | — |  | (45) |  | — |
Total derivative liabilities [3] | (49) |  | — |  | (48) |  | (1) |
Total liabilities accounted for at fair value on a recurring basis | $ | (49) |  | $ | — |  | $ | (48) |  | $ | (1) |
Assets and (Liabilities) Carried at Fair Value by Hierarchy Level as of December 31, 2020
| Total | Quoted Prices in Active Markets for Identical Assets (Level 1) | Significant Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3)
Assets accounted for at fair value on a recurring basis |  |  |  |
Fixed maturities, AFS |  |  |  |
ABS | $ | 1,564 |  | $ | — |  | $ | 1,564 |  | $ | — |
CLOs | 2,780 |  | — |  | 2,420 |  | 360 |
CMBS | 4,484 |  | — |  | 4,407 |  | 77 |
Corporate | 20,273 |  | — |  | 19,392 |  | 881 |
Foreign government/government agencies | 919 |  | — |  | 913 |  | 6 |
Municipal | 9,503 |  | — |  | 9,503 |  | — |
RMBS | 4,107 |  | — |  | 3,726 |  | 381 |
U.S. Treasuries | 1,405 |  | 529 |  | 876 |  | — |
Total fixed maturities | 45,035 |  | 529 |  | 42,801 |  | 1,705 |
Equity securities, at fair value | 1,438 |  | 872 |  | 496 |  | 70 |
Derivative assets |  |  |  |
Credit derivatives | 21 |  | — |  | 21 |  | — |
Foreign exchange derivatives | 1 |  | — |  | 1 |  | — |
Interest rate derivatives | 1 |  | — |  | 1 |  | — |
Total derivative assets [1] | 23 |  | — |  | 23 |  | — |
Short-term investments | 3,283 |  | 2,663 |  | 590 |  | 30 |
Total assets accounted for at fair value on a recurring basis | $ | 49,779 |  | $ | 4,064 |  | $ | 43,910 |  | $ | 1,805 |
Liabilities accounted for at fair value on a recurring basis |  |  |  |
Derivative liabilities |  |  |  |
Foreign exchange derivatives | $ | (14) |  | $ | — |  | $ | (14) |  | $ | — |
Interest rate derivatives | (70) |  | — |  | (70) |  | — |
Total derivative liabilities [3] | (84) |  | — |  | (84) |  | — |
Total liabilities accounted for at fair value on a recurring basis | $ | (84) |  | $ | — |  | $ | (84) |  | $ | — |
[1]Includes derivative instruments in a net positive fair value position after consideration of the accrued interest and impact of collateral posting requirements which may be imposed by agreements and applicable law. See footnote 3 to this table for derivative liabilities. [2]Included within other investments on the Consolidated Balance Sheets. [3]Includes derivative instruments in a net negative fair value position (derivative liability) after consideration of the accrued interest and impact of collateral posting requirements which may be imposed by agreements and applicable law.
Fair Value Inputs, Assets, Quantitative Information | Significant Unobservable Inputs for Level 3 - Securities
Assets accounted for at fair value on a recurring basis | Fair Value | Predominant Valuation Technique | Significant Unobservable Input | Minimum | Maximum | Weighted Average [1] | Impact of Increase in Input on Fair Value [2]
As of December 31, 2021
CLOs [3] | $ | 211 |  | Discounted cash flows | Spread | 234 bps | 258 bps | 257 bps | Decrease
CMBS [3] | $ | 192 |  | Discounted cash flows | Spread (encompasses prepayment, default risk and loss severity) | 203 bps | 468 bps | 266 bps | Decrease
Corporate [4] | $ | 1,532 |  | Discounted cash flows | Spread | 96 bps | 1,227 bps | 298 bps | Decrease
RMBS [3] | $ | 266 |  | Discounted cash flows | Spread [6] | 48 bps | 229 bps | 89 bps | Decrease
|  |  | Constant prepayment rate [6] | 2% | 16% | 7% | Decrease [5]
|  |  | Constant default rate [6] | 1% | 6% | 3% | Decrease
|  |  | Loss severity [6] | —% | 100% | 63% | Decrease
As of December 31, 2020
CLOs [3] | $ | 340 |  | Discounted cash flows | Spread | 304 bps | 305 bps | 304 bps | Decrease
CMBS [3] | $ | 20 |  | Discounted cash flows | Spread (encompasses prepayment, default risk and loss severity) | 255 bps | 975 bps | 688 bps | Decrease
Corporate [4] | $ | 749 |  | Discounted cash flows | Spread | 110 bps | 692 bps | 293 bps | Decrease
RMBS [3] | $ | 364 |  | Discounted cash flows | Spread [6] | 7 bps | 937 bps | 119 bps | Decrease
|  |  | Constant prepayment rate [6] | —% | 10% | 5% | Decrease [5]
|  |  | Constant default rate [6] | 2% | 6% | 3% | Decrease
|  |  | Loss severity [6] | —% | 100% | 84% | Decrease
[1]The weighted average is determined based on the fair value of the securities. [2]Conversely, the impact of a decrease in input would have the opposite impact to the fair value as that presented in the table. [3]Excludes securities for which the Company bases fair value on broker quotations. [4]Excludes securities for which the Company bases fair value on broker quotations; however, included are broker priced lower-rated private placement securities for which the Company receives spread and yield information to corroborate the fair value. [5]Decrease for above market rate coupons and increase for below market rate coupons. [6]Generally, a change in the assumption used for the constant default rate would have been accompanied by a directionally similar change in the assumption used for the loss severity and a directionally opposite change in the assumption used for constant prepayment rate and would have resulted in wider spreads.
Fair Value, Assets (Liabilities) Measured on Recurring Basis, Unobservable Input Reconciliation | Fair Value Rollforwards for Financial Instruments Classified as Level 3 for the Year Ended December 31, 2021
| Total realized/unrealized gains (losses) |  |  |  |  |  |
|  | Fair value as of January 1, 2021 | Included in net income [1] | Included in OCI [2] | Purchases | Settlements | Sales | Transfers into Level 3 [3] | Transfers out of Level 3 [3] | Fair value as of December 31, 2021
Assets |  |  |  |  |  |  |  |  |
Fixed Maturities, AFS |  |  |  |  |  |  |  |  |
| ABS | $ | — |  | $ | — |  | $ | — |  | $ | 42 |  | $ | — |  | $ | (3) |  | $ | — |  | $ | (39) |  | $ | — |
| CLOs | 360 |  | — |  | (1) |  | 471 |  | (124) |  | — |  | — |  | (449) |  | 257 |
| CMBS | 77 |  | — |  | 1 |  | 166 |  | (4) |  | (1) |  | 5 |  | (48) |  | 196 |
| Corporate | 881 |  | 14 |  | (34) |  | 828 |  | (154) |  | (47) |  | 172 |  | (42) |  | 1,618 |
| Foreign Govt./Govt. Agencies | 6 |  | — |  | — |  | 5 |  | — |  | (6) |  | — |  | — |  | 5 |
| RMBS | 381 |  | — |  | (4) |  | 369 |  | (193) |  | (14) |  | — |  | (211) |  | 328 |
Total Fixed Maturities, AFS | 1,705 |  | 14 |  | (38) |  | 1,881 |  | (475) |  | (71) |  | 177 |  | (789) |  | 2,404 |
Equity Securities, at fair value | 70 |  | 42 |  | — |  | 6 |  | (53) |  | (1) |  | — |  | — |  | 64 |
Fixed maturities, FVO [4] | — |  | (6) |  | — |  | 160 |  | 6 |  | — |  | — |  | — |  | 160 |
Short-term investments | 30 |  | — |  | — |  | 98 |  | (48) |  | — |  | — |  | — |  | 80 |
Total Assets | $ | 1,805 |  | $ | 50 |  | $ | (38) |  | $ | 2,145 |  | $ | (570) |  | $ | (72) |  | $ | 177 |  | $ | (789) |  | $ | 2,708 |
Fair Value Rollforwards for Financial Instruments Classified as Level 3 for the Year Ended December 31, 2020
| Total realized/unrealized gains (losses) |  |  |  |  |  |  |
|  | Fair value as of January 1, 2020 | Included in net income [1] | Included in OCI [2] | Purchases | Settlements | Sales | Transfers into Level 3 [3] | Transfers out of Level 3 [3] | Fair value as of December 31, 2020 |
Assets |  |  |  |  |  |  |  |  |  |
Fixed Maturities, AFS |  |  |  |  |  |  |  |  |  |
| ABS | $ | 15 |  | $ | — |  | $ | (1) |  | $ | 43 |  | $ | — |  | $ | — |  | $ | — |  | $ | (57) |  | $ | — |  |
| CLOs | 95 |  | — |  | 1 |  | 389 |  | (43) |  | — |  | — |  | (82) |  | 360 |  |
| CMBS | 9 |  | — |  | 3 |  | 79 |  | (5) |  | — |  | 13 |  | (22) |  | 77 |  |
| Corporate | 732 |  | (31) |  | 31 |  | 272 |  | (143) |  | (36) |  | 486 |  | (430) |  | 881 |  |
| Foreign Govt./Govt. Agencies | 3 |  | — |  | — |  | 6 |  | — |  | — |  | — |  | (3) |  | 6 |  |
| Municipal | — |  | (3) |  | 2 |  | — |  | — |  | (6) |  | 7 |  | — |  | — |  |
| RMBS | 560 |  | — |  | (11) |  | 66 |  | (182) |  | (7) |  | — |  | (45) |  | 381 |  |
Total Fixed Maturities, AFS | 1,414 |  | (34) |  | 25 |  | 855 |  | (373) |  | (49) |  | 506 |  | (639) |  | 1,705 |  |
Equity Securities, at fair value | 73 |  | (10) |  | — |  | 6 |  | — |  | — |  | 1 |  | — |  | 70 |  |
Short-term investments | 15 |  | — |  | — |  | 30 |  | (15) |  | — |  | — |  | — |  | 30 |  |
Total Assets | $ | 1,502 |  | $ | (44) |  | $ | 25 |  | $ | 891 |  | $ | (388) |  | $ | (49) |  | $ | 507 |  | $ | (639) |  | $ | 1,805 |  |
Liabilities |  |  |  |  |  |  |  |  |  |
Derivatives, net [5] |  |  |  |  |  |  |  |  |  |
| Equity | $ | (15) |  | $ | 36 |  | $ | — |  | $ | — |  | $ | (21) |  | $ | — |  | $ | — |  | $ | — |  | $ | — |  |
Total Derivatives, net [5] | (15) |  | 36 |  | — |  | — |  | (21) |  | — |  | — |  | — |  | — |  |
Contingent Considerations | (22) |  | 12 |  | — |  | — |  | 10 |  | — |  | — |  | — |  | — |  |
Total Liabilities | $ | (37) |  | $ | 48 |  | $ | — |  | $ | — |  | $ | (11) |  | $ | — |  | $ | — |  | $ | — |  | $ | — |  |
[1]Amounts in these columns are generally reported in net realized gains (losses). All amounts are before income taxes. [2]All amounts are before income taxes. [3]Transfers in and/or (out) of Level 3 are primarily attributable to the availability of market observable information and the re-evaluation of the observability of pricing inputs. [4]Included within other investments on the Consolidated Balance Sheets. [5]Derivative instruments are reported in this table on a net basis for asset (liability) positions and reported in the Consolidated Balance Sheets in other investments and other liabilities. Changes in Unrealized Gains (Losses) for Financial Instruments Classified as Level 3 Still Held at Year End
|  | December 31, 2021 |  | December 31, 2020
|  | Changes in Unrealized Gain/(Loss) included in Net Income [1] [2] | Changes in Unrealized Gain/(Loss) included in OCI [3] |  | Changes in Unrealized Gain/(Loss) included in Net Income [1] [2] | Changes in Unrealized Gain/(Loss) included in OCI [3]
Assets |  |  |  |  |
Fixed Maturities, AFS |  |  |  |  |
| CLOs | $ | — |  | $ | (1) |  |  | $ | — |  | $ | 1 |
| CMBS | — |  | 1 |  |  | — |  | 4 |
| Corporate | — |  | (32) |  |  | (21) |  | 24 |
| RMBS | — |  | (4) |  |  | — |  | (10) |
Total Fixed Maturities, AFS | — |  | (36) |  |  | (21) |  | 19 |
Equity Securities, at fair value | 4 |  | — |  |  | (9) |  | — |
Fixed Maturities, FVO [4] | (6) |  | — |  |  | — |  | — |
Total Assets | $ | (2) |  | $ | (36) |  |  | $ | (30) |  | $ | 19 |
Liabilities |  |  |  |  |
Contingent Consideration | $ | — |  | $ | — |  |  | $ | 12 |  | $ | — |
Total Liabilities | $ | — |  | $ | — |  |  | $ | 12 |  | $ | — |
[1]All amounts in these rows are reported in net gains (losses). All amounts are before income taxes. [2]Amounts presented are for Level 3 only and therefore may not agree to other disclosures included herein. [3]Changes in unrealized gain (loss) on fixed maturities, AFS are reported in changes in net unrealized gain on securities in the Consolidated Statements of Comprehensive Income. [4]Included within other investments on the Consolidated Balance Sheets.
Schedule of Carrying Values and Estimated Fair Values of Debt Instruments | Financial Assets and Liabilities Not Carried at Fair Value
| December 31, 2021 |  | December 31, 2020
| Fair Value Hierarchy Level | Carrying Amount [1] | Fair Value |  | Fair Value Hierarchy Level | Carrying Amount [1] | Fair Value
Assets |  |  |  |  |  |  |
Mortgage loans | Level 3 | $ | 5,383 |  | $ | 5,576 |  |  | Level 3 | $ | 4,493 |  | $ | 4,792 |
Liabilities |  |  |  |  |  |  |
Other policyholder funds and benefits payable | Level 3 | $ | 687 |  | $ | 689 |  |  | Level 3 | $ | 701 |  | $ | 703 |
Senior notes [2] | Level 2 | $ | 3,854 |  | $ | 4,725 |  |  | Level 2 | $ | 3,262 |  | $ | 4,363 |
Junior subordinated debentures [2] | Level 2 | $ | 1,090 |  | $ | 1,086 |  |  | Level 2 | $ | 1,090 |  | $ | 1,107 |
[1] As of December 31, 2021 and December 31, 2020, carrying amount of mortgage loans is net of ACL of $29 and $38 respectively [2] Included in long-term debt in the Consolidated Balance Sheets, except for any current maturities, which are included in short-term debt when applicable.

X
- Definition Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (bbb) -URI http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) using recurring unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements. + References No definition available. + Details
Name: | us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258 + Details
Name: | us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration